Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

Epilepsy monotherapy approved in Canada

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Advisory committee recommends Taxol for KS

June 27, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Minocycline superior to placebo for early RA

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...